Dianthus Therapeutics (DNTH) Misses Q4 EPS by 81c

Dianthus Therapeutics (NASDAQ: DNTH) reported Q4 EPS of ($0.81). Revenue for the quarter came in at $1.33 million.

For earnings history and earnings-related data on Dianthus Therapeutics (DNTH) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank
• Morgan Stanley Upgrades Galp Energia SGPS SA (GALP:LI) (GLPEF) to Overweight